About Apollo Hospitals Enterprise Limited
Data last updated: 14 July 2026
Apollo Hospitals Enterprise Limited is a public limited company based in Chennai, Tamil Nadu, India. It specialises in hospital and clinical services, a part of the broader healthcare sector. Incorporated on 05 December 1979, the company has been in operation for over 47 years.
Registered with ROC Chennai under CIN L85110TN1979PLC008035. Listed on BSE: 508869 and NSE: APOLLOHOSP.
Capital: an authorised share capital of ₹110 Cr and a paid-up capital of ₹71.89 Cr. It is led by directors including Pratap Chandra Reddy and Shobana Kamineni.
Last AGM: 29 August 2025. Financial statements filed for year ended 31 March 2025. Office: 19 Bishop Gardens R A Puram, Chennai, Tamil Nadu, India – 600028.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹25,229 Cr, a growth of 15.76% compared to the previous year. The net worth stands at ₹9,974.5 Cr (up 15.27% YoY). Total assets are valued at ₹22,197 Cr (up 7.45% YoY).
The company has a workforce of approximately 24,811 employees as per the latest available data. Its group structure includes 34 subsidiaries and 2 joint ventures.
The company is associated with 7 brands, including Apollo Gleneagles Hospitals, Ask Apollo, Apollo Hospitals Bangalore, Apollo Health And Lifestyle, Apollo Hospitals among others. As per MCA filings, the company has open charges of ₹3,978.73 Cr and satisfied charges of ₹5,997.95 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apollohospitals.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address19 Bishop Gardens R A Puram, Chennai, Tamil Nadu, India – 600028
-
IndustryHealthcare, Hospitals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited operates multiple associated brands including Apollo Gleneagles Hospitals, Ask Apollo, and Apollo Hospitals Bangalore. These brands represent Apollo Hospitals Enterprise Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Operates a chain of multispeciality hospitals offering comprehensive care. | apollogleneagles.in | |
| Offers a telemedicine platform provided by Apollo Hospital for remote consultations. | askapollo.com | |
| A chain of multi-speciality hospitals is operated in India. | apollohl.com | |
| Chain of multispecialty hospitals | apollohospitals.com | |
| Online pharmacy with doctor consultations and appointment bookings is provided. | apollo247.com | |
| Chain of multispeciality hospitals | apollobsr.com | |
| Health care services, medical treatments, and informational articles focused on various conditions in Bangalore. | apollohospitalsbangalore.com |
Competitors & Alternatives of Apollo Hospitals Enterprise Limited
Brands and companies operating in the same space as Apollo Hospitals Enterprise Limited include MediBuddy, KIMS Hospitals, CureBay and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Online platform offering multiple healthcare services | Bengaluru, India, India | 2013 |
|
|
Multispeciality secondary and tertiary care is provided by hospital chains. | Secunderabad, India, India | 1999 |
|
|
Healthcare services are delivered via an online platform. | Bhubaneswar, India, India | 2020 |
|
|
Doctor appointments are booked and healthcare professionals are consulted online. | Bengaluru, India, India | 2008 |
|
|
Multi-specialty hospital services are provided across India by Fortis Healthcare. | Gurugram, India, India | 1996 |
|
|
A chain of multi-specialty hospitals is operated in India. | Delhi, India, India | 2011 |
|
|
Chain of multi-speciality hospitals | Chennai, India, India | 1999 |
|
|
Integrated at-home healthcare services, including tele-consultation and diagnostics, are provided. | Hyderabad, India, India | 2013 |
|
|
Digital healthcare tools are offered for pharmacies and clinics management. | Mumbai, India, India | 2012 |
|
|
Multi-speciality hospitals are operated with diverse medical services in India. | Pune, India, India | 1994 |
Business Activity of Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including hospital activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | Locked |
Business activity turnover details for Apollo Hospitals Enterprise Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited is audited by DELOITTE HASKINS & SELLS LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| DELOITTE HASKINS & SELLS LLP (ICAI peer reviewed, certificate valid till 2027-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited is currently managed by 10 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Pratap Chandra Reddy
Also directs:
Apollo Multispeciality Hospitals Limited, Total Health, Imperial Hospital And Research Centre Limited and 5 more
|
Whole-Time Director | 05 Dec 1979 | 46 Years 7 Months | Current |
|
Shobana Kamineni
Also directs:
Pcr Investments Limited, Kamineni Enterprises International Llp, Chola Chiefs Llp and 5 more
|
Director | 02 Jul 2014 | 12 Years 0 Months | Current |
| Konda Sangita Reddy | Whole-Time Director | 03 Feb 2011 | 15 Years 5 Months | Current |
| Pudugramam Murali Doraiswamy | Director | 27 Sep 2018 | 7 Years 9 Months | Current |
| Velagapudi Kavitha Dutt | Director | 09 Feb 2019 | 7 Years 5 Months | Current |
| Bhaskara Mandavilli Nageswara Rao | Director | 09 Feb 2019 | 7 Years 5 Months | Current |
Financials of Apollo Hospitals Enterprise Limited FY 2026 filings available
Apollo Hospitals Enterprise Limited reported revenue of ₹25,229 Cr (up 15.76% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹25,229 Cr | ₹21,794 Cr | ₹19,059 Cr | ₹16,612 Cr | ₹14,663 Cr | ₹10,560 Cr | ₹11,247 Cr |
| Other Income | ₹191.6 Cr | ₹200.3 Cr | ₹106.3 Cr | ₹90.34 Cr | ₹78.14 Cr | ₹44.99 Cr | ₹26.97 Cr |
| Total Income | ₹25,420 Cr | ₹21,994 Cr | ₹19,166 Cr | ₹16,703 Cr | ₹14,741 Cr | ₹10,605 Cr | ₹11,274 Cr |
| Cost of Materials Consumed | ₹3,040.8 Cr | ₹2,754.4 Cr | ₹2,454.1 Cr | ₹2,283.77 Cr | ₹2,685.48 Cr | ₹1,623.31 Cr | ₹1,809.23 Cr |
| Purchases of Stock-in-Trade | ₹10,056 Cr | ₹8,556.7 Cr | ₹7,384.9 Cr | ₹6,315 Cr | ₹4,961.33 Cr | ₹4,186.06 Cr | ₹3,796.67 Cr |
| Changes in Inventories | -₹21.6 Cr | -₹1.1 Cr | -₹33.5 Cr | -₹24.54 Cr | -₹73.34 Cr | -₹125.17 Cr | -₹107.03 Cr |
| Employee Benefit Expense | ₹3,000.3 Cr | ₹2,769.2 Cr | ₹2,493.7 Cr | ₹2,143.78 Cr | ₹1,786.52 Cr | ₹1,600.97 Cr | ₹1,852.92 Cr |
| Finance Costs | ₹449.6 Cr | ₹458.5 Cr | ₹449.4 Cr | ₹380.79 Cr | ₹378.64 Cr | ₹449.22 Cr | ₹532.77 Cr |
| Depreciation & Amortisation | ₹876.1 Cr | ₹757.5 Cr | ₹687 Cr | ₹615.24 Cr | ₹600.7 Cr | ₹573.13 Cr | ₹619.69 Cr |
| Other Expenses | ₹5,383.3 Cr | ₹4,693 Cr | ₹4,369.3 Cr | ₹3,844.83 Cr | ₹3,117.53 Cr | ₹2,137.43 Cr | ₹2,307.72 Cr |
| Total Expenses | ₹22,785 Cr | ₹19,988 Cr | ₹17,805 Cr | ₹15,559 Cr | ₹13,457 Cr | ₹10,445 Cr | ₹10,812 Cr |
| Profit Before Exceptional Items & Tax | ₹2,635.2 Cr | ₹2,006.1 Cr | ₹1,360.6 Cr | ₹1,143.92 Cr | ₹1,283.92 Cr | ₹160.05 Cr | ₹461.8 Cr |
| Exceptional Items | -₹19.2 Cr | ₹0 | ₹1.9 Cr | ₹0 | ₹294.11 Cr | ₹60.65 Cr | ₹198.3 Cr |
| Profit Before Tax | ₹2,616 Cr | ₹2,006.1 Cr | ₹1,362.5 Cr | ₹1,143.92 Cr | ₹1,578.03 Cr | ₹220.7 Cr | ₹660.1 Cr |
| Total Tax Expense | ₹658.2 Cr | ₹534 Cr | ₹445.5 Cr | ₹256.2 Cr | ₹477.02 Cr | ₹84.7 Cr | ₹225.19 Cr |
| Net Profit | ₹2,002.7 Cr | ₹1,505.1 Cr | ₹935 Cr | ₹844.57 Cr | ₹1,108.36 Cr | ₹136.77 Cr | ₹431.8 Cr |
| attributable to Owners | ₹1,941.7 Cr | ₹1,445.9 Cr | ₹898.6 Cr | ₹819.07 Cr | ₹1,055.61 Cr | ₹150.36 Cr | ₹454.94 Cr |
| attributable to NCI | ₹61 Cr | ₹59.2 Cr | ₹36.4 Cr | ₹25.5 Cr | ₹52.75 Cr | -₹13.6 Cr | -₹23.14 Cr |
| Other Comprehensive Income | ₹58.4 Cr | -₹6.3 Cr | -₹10.4 Cr | -₹13.27 Cr | -₹9.72 Cr | ₹15.33 Cr | -₹60 Lakh |
| Total Comprehensive Income | ₹2,061.1 Cr | ₹1,498.8 Cr | ₹924.6 Cr | ₹831.3 Cr | ₹1,098.64 Cr | ₹152.1 Cr | ₹431.2 Cr |
| EBITDA (computed) | ₹3,960.9 Cr | ₹3,222.1 Cr | ₹2,497 Cr | ₹2,139.95 Cr | ₹2,263.26 Cr | ₹1,182.4 Cr | ₹1,614.26 Cr |
| Basic EPS | ₹135.04 | ₹100.56 | ₹62.50 | ₹56.97 | ₹73.42 | ₹10.74 | ₹32.70 |
| Diluted EPS | ₹134.94 | ₹100.56 | ₹62.50 | ₹56.97 | ₹73.42 | ₹10.74 | ₹32.70 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹22,197 Cr | ₹20,657 Cr | ₹16,753 Cr | ₹14,428 Cr |
| Non-current Assets | ₹15,297 Cr | ₹13,629 Cr | ₹11,473 Cr | ₹10,091 Cr |
| Current Assets | ₹6,899.8 Cr | ₹7,028.9 Cr | ₹5,279.7 Cr | ₹4,337.15 Cr |
| Property, Plant & Equipment | ₹11,039 Cr | ₹9,815.7 Cr | ₹8,540.5 Cr | ₹7,432.07 Cr |
| Inventories | ₹542.4 Cr | ₹480.8 Cr | ₹459.8 Cr | ₹390.19 Cr |
| Trade Receivables | ₹3,484.9 Cr | ₹3,016.1 Cr | ₹2,514.9 Cr | ₹2,234.23 Cr |
| Cash & Equivalents | ₹811.3 Cr | ₹578.1 Cr | ₹505.5 Cr | ₹433.42 Cr |
| Equity (Net Worth) | ₹9,974.5 Cr | ₹8,652.9 Cr | ₹7,320.5 Cr | ₹6,531.28 Cr |
| Equity Share Capital | ₹71.9 Cr | ₹71.9 Cr | ₹71.9 Cr | ₹71.89 Cr |
| Borrowings (Non-current) | ₹2,430.1 Cr | ₹4,417 Cr | ₹2,235.6 Cr | ₹1,937.59 Cr |
| Borrowings (Current) | ₹3,228.4 Cr | ₹858.2 Cr | ₹926.3 Cr | ₹772.72 Cr |
| Total Debt (computed) | ₹5,658.5 Cr | ₹5,275.2 Cr | ₹3,161.9 Cr | ₹2,710.31 Cr |
| Current Liabilities | ₹6,481.3 Cr | ₹4,578.9 Cr | ₹4,664.5 Cr | ₹3,324.8 Cr |
| Total Liabilities | ₹12,222 Cr | ₹12,005 Cr | ₹9,432.6 Cr | ₹7,896.45 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹2,855.7 Cr | ₹2,136.4 Cr | ₹1,920.3 Cr | ₹1,377.05 Cr | ₹1,615.64 Cr |
| Investing Cash Flow | -₹2,148.2 Cr | -₹3,380.6 Cr | -₹1,537.1 Cr | -₹856.85 Cr | -₹790.73 Cr |
| Financing Cash Flow | -₹477.6 Cr | ₹1,316.8 Cr | -₹311.2 Cr | -₹633.33 Cr | -₹767.7 Cr |
| Capital Expenditure | ₹1,962 Cr | ₹1,712.7 Cr | ₹1,136.8 Cr | ₹1,128.52 Cr | ₹657.17 Cr |
| Free Cash Flow (computed) | ₹893.7 Cr | ₹423.7 Cr | ₹783.5 Cr | ₹248.53 Cr | ₹958.47 Cr |
| Dividends Paid | ₹292.8 Cr | ₹278.4 Cr | ₹220.9 Cr | ₹257.92 Cr | ₹43.33 Cr |
| Net Change in Cash | ₹229.9 Cr | ₹72.6 Cr | ₹72 Cr | -₹113.13 Cr | ₹57.21 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹6,605.5 Cr | ₹6,477.4 Cr | ₹6,303.5 Cr | ₹5,842.1 Cr | ₹5,592.2 Cr | ₹5,526.9 Cr | ₹5,589.3 Cr | ₹5,085.6 Cr | ₹4,943.9 Cr | ₹4,850.6 Cr | ₹4,846.9 Cr | ₹4,417.8 Cr |
| Other Income | ₹43.9 Cr | ₹52.8 Cr | ₹54.7 Cr | ₹40.2 Cr | ₹61.1 Cr | ₹63.8 Cr | ₹38.2 Cr | ₹37.2 Cr | ₹28.1 Cr | ₹27.8 Cr | ₹22.2 Cr | ₹28.2 Cr |
| Total Income | ₹6,649.4 Cr | ₹6,530.2 Cr | ₹6,358.2 Cr | ₹5,882.3 Cr | ₹5,653.3 Cr | ₹5,590.7 Cr | ₹5,627.5 Cr | ₹5,122.8 Cr | ₹4,972 Cr | ₹4,878.4 Cr | ₹4,869.1 Cr | ₹4,446 Cr |
| Cost of Materials Consumed | ₹777.4 Cr | ₹744.6 Cr | ₹778.7 Cr | ₹740.1 Cr | ₹694.4 Cr | ₹625.6 Cr | ₹744.3 Cr | ₹690.1 Cr | ₹637.5 Cr | ₹603.3 Cr | ₹632.5 Cr | ₹580.8 Cr |
| Purchases of Stock-in-Trade | ₹2,613.1 Cr | ₹2,663.1 Cr | ₹2,464.7 Cr | ₹2,315.5 Cr | ₹2,243.6 Cr | ₹2,292 Cr | ₹2,110.4 Cr | ₹1,910.7 Cr | ₹1,914.1 Cr | ₹1,943.6 Cr | ₹1,840.5 Cr | ₹1,686.7 Cr |
| Changes in Inventories | ₹11.5 Cr | -₹25.3 Cr | ₹20 Lakh | -₹8 Cr | -₹9.4 Cr | -₹16.9 Cr | ₹3 Cr | ₹22.2 Cr | -₹5.9 Cr | -₹13.8 Cr | -₹14.5 Cr | ₹70 Lakh |
| Employee Benefit Expense | ₹772 Cr | ₹749 Cr | ₹766.7 Cr | ₹712.6 Cr | ₹724.6 Cr | ₹686.4 Cr | ₹700.1 Cr | ₹658.1 Cr | ₹644.9 Cr | ₹612.9 Cr | ₹644.1 Cr | ₹591.8 Cr |
| Finance Costs | ₹119.1 Cr | ₹112.6 Cr | ₹109.6 Cr | ₹108.3 Cr | ₹114.8 Cr | ₹109.8 Cr | ₹117.5 Cr | ₹116.4 Cr | ₹119.3 Cr | ₹112.6 Cr | ₹111.3 Cr | ₹106.2 Cr |
| Depreciation & Amortisation | ₹224.4 Cr | ₹219.2 Cr | ₹217.8 Cr | ₹214.7 Cr | ₹211 Cr | ₹184.6 Cr | ₹184.5 Cr | ₹177.4 Cr | ₹189.7 Cr | ₹167 Cr | ₹163.4 Cr | ₹166.9 Cr |
| Other Expenses | ₹1,420.5 Cr | ₹1,380.7 Cr | ₹1,352.1 Cr | ₹1,230 Cr | ₹1,169.3 Cr | ₹1,178.3 Cr | ₹1,216 Cr | ₹1,129.4 Cr | ₹1,112.8 Cr | ₹1,090.9 Cr | ₹1,116.8 Cr | ₹1,048.8 Cr |
| Total Expenses | ₹5,938 Cr | ₹5,843.9 Cr | ₹5,689.8 Cr | ₹5,313.2 Cr | ₹5,148.3 Cr | ₹5,059.8 Cr | ₹5,075.8 Cr | ₹4,704.3 Cr | ₹4,612.4 Cr | ₹4,516.5 Cr | ₹4,494.1 Cr | ₹4,181.9 Cr |
| Profit Before Exceptional Items & Tax | ₹711.4 Cr | ₹686.3 Cr | ₹668.4 Cr | ₹569.1 Cr | ₹505 Cr | ₹530.9 Cr | ₹551.7 Cr | ₹418.5 Cr | ₹359.6 Cr | ₹361.9 Cr | ₹375 Cr | ₹264.1 Cr |
| Exceptional Items | ₹0 | -₹19.2 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹1.9 Cr | ₹0 |
| Profit Before Tax | ₹711.4 Cr | ₹667.1 Cr | ₹668.4 Cr | ₹569.1 Cr | ₹505 Cr | ₹530.9 Cr | ₹551.7 Cr | ₹418.5 Cr | ₹359.6 Cr | ₹361.9 Cr | ₹376.9 Cr | ₹264.1 Cr |
| Total Tax Expense | ₹170.2 Cr | ₹165.7 Cr | ₹180.7 Cr | ₹141.7 Cr | ₹101 Cr | ₹156.8 Cr | ₹161.7 Cr | ₹114.5 Cr | ₹109.8 Cr | ₹108.9 Cr | ₹130.2 Cr | ₹96.6 Cr |
| Net Profit | ₹551.3 Cr | ₹516.3 Cr | ₹494 Cr | ₹441 Cr | ₹414.5 Cr | ₹379.4 Cr | ₹395.7 Cr | ₹315.5 Cr | ₹258.4 Cr | ₹254.4 Cr | ₹248.8 Cr | ₹173.4 Cr |
| attributable to Owners | ₹529.3 Cr | ₹502.3 Cr | ₹477.2 Cr | ₹432.8 Cr | ₹389.6 Cr | ₹372.3 Cr | ₹378.8 Cr | ₹305.2 Cr | ₹253.8 Cr | ₹245.3 Cr | ₹232.9 Cr | ₹166.6 Cr |
| attributable to NCI | ₹22 Cr | ₹14 Cr | ₹16.8 Cr | ₹8.2 Cr | ₹24.9 Cr | ₹7.1 Cr | ₹16.9 Cr | ₹10.3 Cr | ₹4.6 Cr | ₹9.1 Cr | ₹15.9 Cr | ₹6.8 Cr |
| Other Comprehensive Income | -₹4.1 Cr | -₹20 Lakh | ₹56.8 Cr | ₹5.9 Cr | -₹3 Cr | -₹2.9 Cr | -₹5.5 Cr | ₹5.2 Cr | -₹20 Lakh | ₹80 Lakh | -₹9.26 Cr | -₹1.8 Cr |
| Total Comprehensive Income | ₹547.2 Cr | ₹516.1 Cr | ₹550.8 Cr | ₹446.9 Cr | ₹411.5 Cr | ₹376.5 Cr | ₹390.2 Cr | ₹320.7 Cr | ₹258.2 Cr | ₹255.2 Cr | ₹239.54 Cr | ₹171.6 Cr |
| EBITDA (computed) | ₹1,054.9 Cr | ₹1,018.1 Cr | ₹995.8 Cr | ₹892.1 Cr | ₹830.8 Cr | ₹825.3 Cr | ₹853.7 Cr | ₹712.3 Cr | ₹668.6 Cr | ₹641.5 Cr | ₹649.7 Cr | ₹537.2 Cr |
| Basic EPS | ₹36.82 | ₹34.94 | ₹33.19 | ₹30.10 | ₹27.10 | ₹25.89 | ₹26.34 | ₹21.23 | ₹17.65 | ₹17.06 | ₹16.20 | ₹11.59 |
| Diluted EPS | ₹36.76 | ₹34.94 | ₹33.19 | ₹30.10 | ₹27.10 | ₹25.89 | ₹26.34 | ₹21.23 | ₹17.65 | ₹17.06 | ₹16.20 | ₹11.59 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Healthcare services | ₹3,333.7 Cr | ₹614.6 Cr | ₹14,486 Cr | ₹3,935.7 Cr |
| Retail health & diagnostics | ₹489.5 Cr | ₹39.9 Cr | ₹1,473.2 Cr | ₹1,143.6 Cr |
| Digital health & pharmacy distribution | ₹2,848.2 Cr | ₹135.7 Cr | ₹3,318.1 Cr | ₹946.6 Cr |
| Others | ₹1.3 Cr | -₹3.7 Cr | ₹25.7 Cr | ₹18.3 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Healthcare services | ₹12,750 Cr | ₹2,430.3 Cr | - | - |
| Retail health & diagnostics | ₹1,865.3 Cr | ₹72.3 Cr | - | - |
| Digital health & pharmacy distribution | ₹10,808 Cr | ₹398.7 Cr | - | - |
| Others | ₹5.2 Cr | -₹8.1 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹9,326.2 Cr | ₹8,202.1 Cr | ₹7,273.8 Cr | ₹6,524.84 Cr | ₹6,098.33 Cr | ₹9,153.04 Cr | ₹9,794.43 Cr |
| Other Income | ₹371.8 Cr | ₹347.7 Cr | ₹179.9 Cr | ₹151.51 Cr | ₹46.99 Cr | ₹18.15 Cr | ₹10.91 Cr |
| Total Income | ₹9,698 Cr | ₹8,549.8 Cr | ₹7,453.7 Cr | ₹6,676.35 Cr | ₹6,145.32 Cr | ₹9,171.19 Cr | ₹9,805.34 Cr |
| Cost of Materials Consumed | ₹2,418.8 Cr | ₹2,248.4 Cr | ₹1,999 Cr | ₹1,861.11 Cr | ₹1,929.33 Cr | ₹1,329.86 Cr | ₹1,532.12 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹4,155.2 Cr | ₹3,754.19 Cr |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹127.63 Cr | -₹104.33 Cr |
| Employee Benefit Expense | ₹1,686.2 Cr | ₹1,596.8 Cr | ₹1,425.2 Cr | ₹1,239.46 Cr | ₹1,150.48 Cr | ₹1,275.11 Cr | ₹1,519.18 Cr |
| Finance Costs | ₹241.7 Cr | ₹254 Cr | ₹249.8 Cr | ₹238.8 Cr | ₹244.04 Cr | ₹343.8 Cr | ₹425.88 Cr |
| Depreciation & Amortisation | ₹500.4 Cr | ₹449.4 Cr | ₹399 Cr | ₹366.69 Cr | ₹363.42 Cr | ₹435.95 Cr | ₹482.26 Cr |
| Other Expenses | ₹2,893.2 Cr | ₹2,312.7 Cr | ₹2,052.1 Cr | ₹1,742.78 Cr | ₹1,599.18 Cr | ₹1,573.09 Cr | ₹1,678.03 Cr |
| Total Expenses | ₹7,740.3 Cr | ₹6,861.3 Cr | ₹6,125.1 Cr | ₹5,448.84 Cr | ₹5,286.45 Cr | ₹8,985.38 Cr | ₹9,287.33 Cr |
| Profit Before Exceptional Items & Tax | ₹1,957.7 Cr | ₹1,688.5 Cr | ₹1,328.6 Cr | ₹1,227.51 Cr | ₹858.87 Cr | ₹185.81 Cr | ₹518.01 Cr |
| Exceptional Items | -₹11.4 Cr | ₹0 | ₹0 | ₹0 | -₹6.74 Cr | -₹9.09 Cr | ₹164.35 Cr |
| Profit Before Tax | ₹1,946.3 Cr | ₹1,688.5 Cr | ₹1,328.6 Cr | ₹1,227.51 Cr | ₹852.13 Cr | ₹176.72 Cr | ₹682.36 Cr |
| Total Tax Expense | ₹453.7 Cr | ₹392.2 Cr | ₹318.1 Cr | ₹142.73 Cr | ₹279.79 Cr | ₹71.57 Cr | ₹212.11 Cr |
| Net Profit | ₹1,492.6 Cr | ₹1,296.3 Cr | ₹1,010.5 Cr | ₹1,084.78 Cr | ₹665.03 Cr | ₹105.15 Cr | ₹470.25 Cr |
| attributable to Owners | - | - | - | - | - | - | ₹470.25 Cr |
| Other Comprehensive Income | -₹11.6 Cr | ₹20 Lakh | -₹8.5 Cr | -₹11.14 Cr | -₹2.24 Cr | -₹5.58 Cr | ₹75 Lakh |
| Total Comprehensive Income | ₹1,481 Cr | ₹1,296.5 Cr | ₹1,002 Cr | ₹1,073.64 Cr | ₹662.79 Cr | ₹99.57 Cr | ₹471 Cr |
| EBITDA (computed) | ₹2,699.8 Cr | ₹2,391.9 Cr | ₹1,977.4 Cr | ₹1,833 Cr | ₹1,466.33 Cr | ₹965.56 Cr | ₹1,426.15 Cr |
| Basic EPS | ₹103.81 | ₹90.15 | ₹70.28 | ₹75.45 | ₹39.81 | ₹7.51 | ₹33.80 |
| Diluted EPS | ₹103.74 | ₹90.15 | ₹70.28 | ₹75.45 | ₹39.81 | ₹7.51 | ₹33.80 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹14,915 Cr | ₹13,372 Cr | ₹12,405 Cr | ₹10,780 Cr |
| Non-current Assets | ₹12,064 Cr | ₹9,853.9 Cr | ₹8,730.1 Cr | ₹7,629.67 Cr |
| Current Assets | ₹2,850.4 Cr | ₹3,518.4 Cr | ₹3,675.1 Cr | ₹3,150.59 Cr |
| Property, Plant & Equipment | ₹6,821.9 Cr | ₹6,239 Cr | ₹5,970.8 Cr | ₹5,049.41 Cr |
| Inventories | ₹146.8 Cr | ₹126.6 Cr | ₹118.7 Cr | ₹98.3 Cr |
| Trade Receivables | ₹847.3 Cr | ₹814.8 Cr | ₹808.3 Cr | ₹819.97 Cr |
| Cash & Equivalents | ₹342.6 Cr | ₹233.2 Cr | ₹276.1 Cr | ₹217.01 Cr |
| Equity (Net Worth) | ₹9,963.2 Cr | ₹8,734.2 Cr | ₹7,710.9 Cr | ₹6,924.74 Cr |
| Equity Share Capital | ₹71.9 Cr | ₹71.9 Cr | ₹71.9 Cr | ₹71.89 Cr |
| Borrowings (Non-current) | ₹1,625 Cr | ₹1,553.5 Cr | ₹1,785.5 Cr | ₹1,520.12 Cr |
| Borrowings (Current) | ₹197.2 Cr | ₹229.7 Cr | ₹170.2 Cr | ₹240.46 Cr |
| Total Debt (computed) | ₹1,822.2 Cr | ₹1,783.2 Cr | ₹1,955.7 Cr | ₹1,760.58 Cr |
| Current Liabilities | ₹1,641.6 Cr | ₹1,440.7 Cr | ₹1,370.2 Cr | ₹1,243.2 Cr |
| Total Liabilities | ₹4,951.3 Cr | ₹4,638.1 Cr | ₹4,694.3 Cr | ₹3,855.52 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹2,059 Cr | ₹1,741.9 Cr | ₹1,191.4 Cr | ₹1,224.23 Cr | ₹1,200.87 Cr |
| Investing Cash Flow | -₹1,413 Cr | -₹1,045.7 Cr | -₹835.3 Cr | -₹588.23 Cr | -₹444.6 Cr |
| Financing Cash Flow | -₹536.7 Cr | -₹739.1 Cr | -₹297 Cr | -₹778.62 Cr | -₹637.22 Cr |
| Capital Expenditure | ₹1,052.9 Cr | ₹858.2 Cr | ₹621 Cr | ₹395.86 Cr | ₹462.86 Cr |
| Free Cash Flow (computed) | ₹1,006.1 Cr | ₹883.7 Cr | ₹570.4 Cr | ₹828.37 Cr | ₹738.01 Cr |
| Dividends Paid | ₹287.6 Cr | ₹273.2 Cr | ₹215.7 Cr | ₹255.22 Cr | ₹43.14 Cr |
| Net Change in Cash | ₹109.3 Cr | -₹42.9 Cr | ₹59.1 Cr | -₹142.62 Cr | ₹119.05 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2,438.5 Cr | ₹2,363.7 Cr | ₹2,356.1 Cr | ₹2,167.9 Cr | ₹2,075.3 Cr | ₹2,054.8 Cr | ₹2,135.4 Cr | ₹1,936.6 Cr | ₹1,894.6 Cr | ₹1,824.3 Cr | ₹1,866.5 Cr | ₹1,688.4 Cr |
| Other Income | ₹90.3 Cr | ₹108 Cr | ₹141.1 Cr | ₹32.5 Cr | ₹91.6 Cr | ₹107.9 Cr | ₹120.9 Cr | ₹27.3 Cr | ₹46 Cr | ₹51.6 Cr | ₹64.6 Cr | ₹17.8 Cr |
| Total Income | ₹2,528.8 Cr | ₹2,471.7 Cr | ₹2,497.2 Cr | ₹2,200.4 Cr | ₹2,166.9 Cr | ₹2,162.7 Cr | ₹2,256.3 Cr | ₹1,963.9 Cr | ₹1,940.6 Cr | ₹1,875.9 Cr | ₹1,931.1 Cr | ₹1,706.2 Cr |
| Cost of Materials Consumed | ₹606.2 Cr | ₹611.7 Cr | ₹611.2 Cr | ₹589.7 Cr | ₹562 Cr | ₹569.3 Cr | ₹580.9 Cr | ₹536.2 Cr | ₹526.6 Cr | ₹496.5 Cr | ₹514.2 Cr | ₹461.7 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹441.2 Cr | ₹410.1 Cr | ₹431.2 Cr | ₹403.7 Cr | ₹410.2 Cr | ₹393.5 Cr | ₹412.4 Cr | ₹380.7 Cr | ₹383.9 Cr | ₹350.1 Cr | ₹357.8 Cr | ₹333.4 Cr |
| Finance Costs | ₹63.4 Cr | ₹61.7 Cr | ₹57.9 Cr | ₹58.8 Cr | ₹63.1 Cr | ₹62 Cr | ₹65.4 Cr | ₹63.5 Cr | ₹68.7 Cr | ₹60.6 Cr | ₹59.6 Cr | ₹60.9 Cr |
| Depreciation & Amortisation | ₹128 Cr | ₹126.8 Cr | ₹122.4 Cr | ₹123.2 Cr | ₹129.8 Cr | ₹108.4 Cr | ₹108.3 Cr | ₹102.9 Cr | ₹115.3 Cr | ₹97.2 Cr | ₹93.4 Cr | ₹93.1 Cr |
| Other Expenses | ₹795.6 Cr | ₹748.4 Cr | ₹720.8 Cr | ₹628.4 Cr | ₹581.8 Cr | ₹580.2 Cr | ₹601.8 Cr | ₹548.9 Cr | ₹533.7 Cr | ₹527.4 Cr | ₹515.4 Cr | ₹475.6 Cr |
| Total Expenses | ₹2,034.4 Cr | ₹1,958.7 Cr | ₹1,943.5 Cr | ₹1,803.8 Cr | ₹1,746.9 Cr | ₹1,713.4 Cr | ₹1,768.8 Cr | ₹1,632.2 Cr | ₹1,628.2 Cr | ₹1,531.8 Cr | ₹1,540.4 Cr | ₹1,424.7 Cr |
| Profit Before Exceptional Items & Tax | ₹494.4 Cr | ₹513 Cr | ₹553.7 Cr | ₹396.6 Cr | ₹420 Cr | ₹449.3 Cr | ₹487.5 Cr | ₹331.7 Cr | ₹312.4 Cr | ₹344.1 Cr | ₹390.7 Cr | ₹281.5 Cr |
| Exceptional Items | ₹0 | -₹11.4 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹494.4 Cr | ₹501.6 Cr | ₹553.7 Cr | ₹396.6 Cr | ₹420 Cr | ₹449.3 Cr | ₹487.5 Cr | ₹331.7 Cr | ₹312.4 Cr | ₹344.1 Cr | ₹390.7 Cr | ₹281.5 Cr |
| Total Tax Expense | ₹112 Cr | ₹118.1 Cr | ₹133.8 Cr | ₹89.7 Cr | ₹86.6 Cr | ₹107.7 Cr | ₹117.9 Cr | ₹80 Cr | ₹73.6 Cr | ₹81.2 Cr | ₹95.9 Cr | ₹67.4 Cr |
| Net Profit | ₹382.4 Cr | ₹383.5 Cr | ₹419.9 Cr | ₹306.9 Cr | ₹333.4 Cr | ₹341.6 Cr | ₹369.6 Cr | ₹251.7 Cr | ₹238.8 Cr | ₹262.9 Cr | ₹294.8 Cr | ₹214.1 Cr |
| Other Comprehensive Income | -₹6.8 Cr | -₹2.4 Cr | -₹8.1 Cr | ₹5.7 Cr | ₹10 Lakh | -₹2.5 Cr | -₹2.4 Cr | ₹5 Cr | ₹30 Lakh | ₹80 Lakh | -₹8 Cr | -₹1.6 Cr |
| Total Comprehensive Income | ₹375.6 Cr | ₹381.1 Cr | ₹411.8 Cr | ₹312.6 Cr | ₹333.5 Cr | ₹339.1 Cr | ₹367.2 Cr | ₹256.7 Cr | ₹239.1 Cr | ₹263.7 Cr | ₹286.8 Cr | ₹212.5 Cr |
| EBITDA (computed) | ₹685.8 Cr | ₹701.5 Cr | ₹734 Cr | ₹578.6 Cr | ₹612.9 Cr | ₹619.7 Cr | ₹661.2 Cr | ₹498.1 Cr | ₹496.4 Cr | ₹501.9 Cr | ₹543.7 Cr | ₹435.5 Cr |
| Basic EPS | ₹26.59 | ₹26.67 | ₹29.20 | ₹21.35 | ₹23.18 | ₹23.76 | ₹25.71 | ₹17.51 | ₹16.61 | ₹18.28 | ₹20.50 | ₹14.89 |
| Diluted EPS | ₹26.56 | ₹26.67 | ₹29.20 | ₹21.35 | ₹23.18 | ₹23.76 | ₹25.71 | ₹17.51 | ₹16.61 | ₹18.28 | ₹20.50 | ₹14.89 |
| Segment · FY 2022 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Others | ₹0 | ₹0 | - | - |
| healthcare | ₹6,099.83 Cr | ₹1,055.92 Cr | - | - |
Shareholding Pattern of Apollo Hospitals Enterprise Limited
As per the shareholding pattern filed with NSE for the quarter ended Jun 2026, promoters hold 28.02%, foreign institutional investors hold 41.50%, domestic institutional investors hold 23.72%, retail and other public shareholders hold 6.54% of Apollo Hospitals Enterprise Limited. The company had 174,281 shareholders on record.
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 28.02% | 28.02% | 28.02% | 28.02% | 29.34% | 29.34% |
| Public | 71.98% | 71.98% | 71.98% | 71.98% | 70.66% | 70.66% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 28.02% | 29.34% | 29.33% | 29.33% | 29.33% | 29.82% | 30.81% | 34.40% | 34.39% | 34.35% | 34.35% |
| Public | 71.98% | 70.66% | 70.67% | 70.67% | 70.67% | 70.18% | 69.19% | 65.60% | 65.61% | 65.65% | 65.65% |
| Promoter change (YoY, %pts) | -1.32 | +0.01 | +0.00 | +0.00 | -0.49 | -0.99 | -3.59 | +0.01 | +0.04 | +0.00 | - |
Board & Governance of Apollo Hospitals Enterprise Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Apollo Hospitals Enterprise Limited has 10 directors - 5 independent and 4 executive. The board is chaired by PRATAP C REDDY.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| PRATAP C REDDY | Executive Director · Chairperson | 1979-12-05 | 2 |
| PREETHA REDDY | Executive Director | 1989-02-03 | 3 |
| SUNEETA REDDY | Executive Director · MD | 2000-05-01 | 4 |
| SHOBANA KAMINENI | Non-Executive - Non Independent Director | 2010-02-01 | 1 |
| SANGITA REDDY | Executive Director | 2000-07-31 | 3 |
| PUDUGRAMAM MURALI DORAISWAMY | Non-Executive - Independent Director | 2018-09-27 | 1 |
| MANDAVILLI BHASKARA NAGESWARA RAO | Non-Executive - Independent Director | 2019-02-09 | 1 |
| VELAGAPUDI KAVITHA V DUTT | Non-Executive - Independent Director | 2019-02-09 | 4 |
| SOM MITTAL | Non-Executive - Independent Director | 2021-07-21 | 3 |
| RAMA BIJAPURKAR | Non-Executive - Independent Director | 2021-11-12 | 4 |
| Committee | Members |
|---|---|
| Audit Committee | MANDAVILLI BHASKARA NAGESWARA RAO (Chairperson), VELAGAPUDI KAVITHA V DUTT, SOM MITTAL |
| Nomination and remuneration committee | PUDUGRAMAM MURALI DORAISWAMY (Chairperson), MANDAVILLI BHASKARA NAGESWARA RAO, RAMA BIJAPURKAR |
| Stakeholders Relationship Committee | VELAGAPUDI KAVITHA V DUTT (Chairperson), PREETHA REDDY, SUNEETA REDDY |
| Risk Management Committee | SUNEETA REDDY (Chairperson), PREETHA REDDY, VELAGAPUDI KAVITHA V DUTT, DR MADHU SASIDHAR, DR ROHINI SRIDHAR |
| Corporate Social Responsibility Committee | PRATAP C REDDY (Chairperson), PREETHA REDDY, SUNEETA REDDY, SANGITA REDDY, MANDAVILLI BHASKARA NAGESWARA RAO, PUDUGRAMAM MURALI DORAISWAMY |
| INVESTMENT COMMITTEE | MANDAVILLI BHASKARA NAGESWARA RAO (Chairperson), PUDUGRAMAM MURALI DORAISWAMY, PREETHA REDDY, SUNEETA REDDY, VELAGAPUDI KAVITHA V DUTT |
Group Structure of Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has 34 subsidiary companies, 2 joint ventures, and 3 associated companies. This group structure data is as of FY 2024. The corporate group structure reflects Apollo Hospitals Enterprise Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Apollo Multispeciality Hospitals Limited | U33112WB1988PLC045223 | - |
| Future Parking Private Limited | U45206TN2009PTC072304 | - |
| Health Axis Private Limited | U62099TN2023PTC161547 | - |
| Ahll Risk Management Private Limited | U66000TG2018PTC125224 | - |
| Sobhagya Hospital And Research Centre Private Limited | U68100MP1992PTC007118 | - |
| Sapien Biosciences Private Limited | U73100TG2012PTC080254 | - |
Showing major subsidiaries. Total: 34.
Charges & Borrowings of Apollo Hospitals Enterprise Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2026 | Bank of India | ₹500 Cr | Open |
| 31 May 2023 | State Bank of India | ₹350 Cr | Open |
| 03 Sep 2021 | Others | ₹200 Cr | Open |
| 16 Jul 2021 | Bank of India | ₹300 Cr | Open |
| 01 Jun 2021 | Axis Bank Limited | ₹500 Cr | Open |
Total charge records: 110 View all charges
Employees and EPFO Compliance at Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has a workforce of 24,811 employees as of Feb 03, 2026.
Employee and EPFO history for Apollo Hospitals Enterprise Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Apollo Hospitals Enterprise Limited
GST registrations and filing compliance for Apollo Hospitals Enterprise Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Apollo Hospitals Enterprise Limited
Credit ratings, litigation, and regulatory alerts for Apollo Hospitals Enterprise Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apollo Hospitals Enterprise Limited
MSME payment history for Apollo Hospitals Enterprise Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apollo Hospitals Enterprise Limited
Corporate group structure for Apollo Hospitals Enterprise Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apollo Hospitals Enterprise Limited
MCA filings and documents for Apollo Hospitals Enterprise Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Apollo Hospitals Enterprise Limited
Recent News on Apollo Hospitals Enterprise Limited
Frequently Asked Questions about Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited is an active public limited company in the healthcare sector based in Chennai, Tamil Nadu, India. It was incorporated on 05 December 1979 (47+ years old) and is registered under CIN L85110TN1979PLC008035. Listed on BSE: 508869 and NSE: APOLLOHOSP. The company has 24,811 employees.
Apollo Hospitals Enterprise Limited reported revenue of ₹25,229 Cr for FY 2026 (up 15.76% YoY) based on consolidated NSE filings.
The current directors of Apollo Hospitals Enterprise Limited are:
- Pratap Chandra Reddy - Whole-Time Director
- Shobana Kamineni - Director
- Konda Sangita Reddy - Whole-Time Director
- Pudugramam Murali Doraiswamy - Director
- Velagapudi Kavitha Dutt - Director
- Bhaskara Mandavilli Nageswara Rao - Director
- Som Mittal - Director
- Preetha Reddy - Whole-Time Director
- Suneeta Reddy - Managing Director
- Rama Bijapurkar - Director
The primary industry of Apollo Hospitals Enterprise Limited is healthcare. The company specifically operates in hospitals. The company is currently active in this sector.
Yes. Apollo Hospitals Enterprise Limited is listed on both BSE (code: 508869) and NSE (symbol: APOLLOHOSP).
Apollo Hospitals Enterprise Limited can be reached at the registered office: 19 Bishop Gardens R A Puram, Chennai, Tamil Nadu, India – 600028, or through the website apollohospitals.com.